Moreover, residual confounding by unmeasured comorbidities (i.e., peripheral neuropathy and microvascular disease) or lifestyle factors (e.g., physical activity, dietary patterns) might influence both sclerostin levels and the risk of PAD. Here, SOST is linked to peripheral neuropathy.